Q1: 2026-04-29 Earnings Summary
EPS of $0.53 beats by $0.07
|
Revenue of
$3.98B
(2.34% Y/Y)
beats by $194.75M
Teva Pharmaceutical Industries Limited (TEVA) Q1 2026 Earnings Call April 29, 2026 8:00 AM EDT
Company Participants
Christopher Stevo - Senior Vice President of Investor Relations & Competitive Intelligence
Richard Francis - President, CEO & Director
Eric Hughes - Executive VP of Global R&D and Chief Medical Officer
Eliyahu Kalif - Executive VP & CFO
Conference Call Participants
Louise Chen - Scotiabank Global Banking and Markets, Research Division
Glen Santangelo - Barclays Bank PLC, Research Division
Matthew Dellatorre - Goldman Sachs Group, Inc., Research Division
Dennis Ding
Jason Gerberry - BofA Securities, Research Division
Umer Raffat - Evercore ISI Institutional Equities, Research Division
David Amsellem - Piper Sandler & Co., Research Division
Christopher Schott - JPMorgan Chase & Co, Research Division
Ashwani Verma - UBS Investment Bank, Research Division
Leszek Sulewski - Truist Securities, Inc., Research Division
Presentation
Operator
Hello, and welcome to the Teva Pharmaceutical Industries Limited Q1 2026 Earnings Conference Call. My name is Alex and I'll be coordinating today's call. [Operator Instructions]
I'll now hand it over to Chris Stevo, SVP, Investor Relations. Please go ahead.
Christopher Stevo
Senior Vice President of Investor Relations & Competitive Intelligence
Thank you, Alex. Good morning and good afternoon, everyone. Thank you for joining us on our first quarter call. I'd like to note that before we posted our press release this morning on earnings, we also posted a press release on the Emalex transaction as well as the slide deck relating to that transaction. And you can find those materials in the same section as you can find our earnings materials.
Before I turn the call over to our CEO, Richard Francis, I want to remind everyone that we will be making forward-looking statements on this call. The company cautions investors that any forward-looking statement involves risks and uncertainties and is not a guarantee of future performance.
Actual results may
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。